Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...
Abstract: The promise of model-predictive control (MPC) in robotics has led to extensive development of efficient numerical optimal control solvers in line with differential dynamic programming ...
OU Online’s MS in Sustainability prepares students for career changes, advancement, and leadership in a growing sector impacting industries and organizations around the world. f. Students are welcome ...
Even before large pieces of the federal government shut down in October 2025, the Supplemental Nutrition Assistance Program, or SNAP – sometimes called the food stamp program – was in for some big ...
Eriez, an Erie, Pennsylvania-based magnetic separation and material handling technology company, has expanded its Quick Ship program to provide faster turnarounds for customers in North America. The ...
PORTSMOUTH, N.H.--(BUSINESS WIRE)-- Albany International Corp. (NYSE: AIN) announced today that it is exploring strategic alternatives for its structures assembly business, including a potential sale ...
Powered by 25 years of research, this program pairs patented nutrition technology with personalized medical nutrition to rebuild metabolic and heart health. LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback